| Net Cash Provided by (Used in) Operating Activities |
$55,743,175 |
USD |
-213% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$58,942,462 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
82,653,798 |
shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$45,077,468 |
USD |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$43,521,159 |
USD |
35% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$15,156,793 |
USD |
-6.1% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
$157,176 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$807,755,805 |
USD |
16% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$60,467,347 |
USD |
-3.7% |
Q2 2025 |
Q2 2025 |